MeSH D013313 - post-traumatic stress disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Paroxetine | Paroxetine |  | 2007-06-29 |  |  |
| Sertraline | Sertraline |  | 2006-06-30 |  |  | |
| Glenmark Pharmaceuticals | Lithium | Lithium |  | 2009-02-03 |  |  |
| Mylan | Lithium | Lithium |  | 2002-06-27 |  |  |
| Paroxetine | Paroxetine |  | 2004-03-08 |  |  | |
| Sertraline | Sertraline |  | 2007-03-20 |  |  | |
| Cipla | Sertraline | Sertraline |  | 2007-02-06 |  |  |
| Lupin Research | Paroxetine | Paroxetine |  | 2017-01-20 |  |  |
| Sertraline | Sertraline |  | 2007-02-06 |  |  | |
| Bayer | Lithium | Lithane |  | 1985-07-18 |  |  |
| Pfizer | Lithium | Lithium |  | 1982-01-01 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
77%27/35
Phase 2
53%38/72
Phase 3
45%21/47
Approved: 7Overall Success rate: 18%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use